Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
December 21, 2011
Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2003
Generation and characterization of highly constitutive active histamine H3 receptors
Kazuhiko Takahashi, Shigeru Tokita, Hidehito Kotani
Journal of Pharmacological Sciences
|
May 2, 2006
Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders
Shigeru Tokita, Kazuhiko Takahashi, Hidehito Kotani
European Journal of Pharmacology
|
November 27, 2007
Distinctive role of central histamine H3 receptor in various orexigenic pathways
Ryo Yoshimoto, Akio Kanatani, Shigeru Tokita
Journal of Diabetes Investigation
|
October 17, 2018
Retrospective analysis of medical costs and resource utilization for severe hypoglycemic events in patients with type 2 diabetes in Japan
Yuika Ikeda, Takekazu Kubo, Eisei Oda, et al.
Journal of Diabetes Investigation
|
November 25, 2017
Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: Retrospective Diagnosis Procedure Combination database analysis
Yuika Ikeda, Takekazu Kubo, Eisei Oda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
December 3, 2019
[Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes]
Ai Hayashi, Takekazu Kubo, Kotoba Okuyama, et al.
Lipids
|
July 4, 2009
Development of a high-density assay for long-chain fatty acyl-CoA elongases
Hidefumi Kitazawa, Yasuhisa Miyamoto, Ken Shimamura, et al.
BMC Pulmonary Medicine
|
October 1, 2022
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Naoya Ueda, Anzu Yakushiji, Jonathan Schelfhout, et al.
Diabetes & Metabolic Syndrome
|
July 25, 2019
Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: An observational patient-reported study
Takekazu Kubo, Kotoba Okuyama, Xiahong Zhao, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
December 21, 2011
Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2003
Generation and characterization of highly constitutive active histamine H3 receptors
Kazuhiko Takahashi, Shigeru Tokita, Hidehito Kotani
Journal of Pharmacological Sciences
|
May 2, 2006
Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders
Shigeru Tokita, Kazuhiko Takahashi, Hidehito Kotani
European Journal of Pharmacology
|
November 27, 2007
Distinctive role of central histamine H3 receptor in various orexigenic pathways
Ryo Yoshimoto, Akio Kanatani, Shigeru Tokita
Journal of Diabetes Investigation
|
October 17, 2018
Retrospective analysis of medical costs and resource utilization for severe hypoglycemic events in patients with type 2 diabetes in Japan
Yuika Ikeda, Takekazu Kubo, Eisei Oda, et al.
Journal of Diabetes Investigation
|
November 25, 2017
Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: Retrospective Diagnosis Procedure Combination database analysis
Yuika Ikeda, Takekazu Kubo, Eisei Oda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
December 3, 2019
[Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes]
Ai Hayashi, Takekazu Kubo, Kotoba Okuyama, et al.
Lipids
|
July 4, 2009
Development of a high-density assay for long-chain fatty acyl-CoA elongases
Hidefumi Kitazawa, Yasuhisa Miyamoto, Ken Shimamura, et al.
BMC Pulmonary Medicine
|
October 1, 2022
Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Naoya Ueda, Anzu Yakushiji, Jonathan Schelfhout, et al.
Diabetes & Metabolic Syndrome
|
July 25, 2019
Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: An observational patient-reported study
Takekazu Kubo, Kotoba Okuyama, Xiahong Zhao, et al.
Page
of 7